antibiotic resistant

简明释义

耐抗生家的

英英释义

例句

1.Public health campaigns aim to reduce the prevalence of antibiotic resistant (抗生素耐药) bacteria.

公共卫生运动旨在减少抗生素耐药细菌的流行。

2.Patients with antibiotic resistant (抗生素耐药) infections may require longer hospital stays.

患有抗生素耐药感染的患者可能需要更长的住院时间。

3.In recent years, many infections have become antibiotic resistant (抗生素耐药), making treatment more difficult.

近年来，许多感染变得抗生素耐药，使治疗更加困难。

4.The doctor prescribed a different medication because the bacteria were antibiotic resistant (抗生素耐药).

医生开了另一种药物，因为细菌是抗生素耐药的。

5.Hospitals are seeing an increase in antibiotic resistant (抗生素耐药) strains of bacteria.

医院看到抗生素耐药的细菌株增加。

作文

Antibiotics have been a cornerstone of modern medicine, revolutionizing the way we treat infections and save lives. However, the emergence of antibiotic resistant (抗生素耐药) bacteria poses a significant threat to global health. This phenomenon occurs when bacteria evolve and develop the ability to survive exposure to antibiotics that once effectively killed them. As a result, infections that were once easily treatable are becoming increasingly difficult to manage, leading to longer hospital stays, higher medical costs, and increased mortality rates.The rise of antibiotic resistant (抗生素耐药) bacteria can be attributed to several factors, primarily the overuse and misuse of antibiotics in both humans and animals. In many cases, patients do not complete their prescribed antibiotic courses, allowing some bacteria to survive and adapt. Furthermore, antibiotics are often used in livestock farming to promote growth and prevent disease, which contributes to the spread of resistance into the human population through the food chain.Another contributing factor is the lack of new antibiotics being developed. The pharmaceutical industry has shifted its focus towards more profitable medications, leaving a significant gap in the availability of new treatments for antibiotic resistant (抗生素耐药) infections. This stagnation in antibiotic development means that healthcare providers have fewer options to treat infections that no longer respond to standard therapies.The consequences of antibiotic resistant (抗生素耐药) infections are dire. According to the World Health Organization (WHO), it is estimated that by 2050, if no action is taken, drug-resistant infections could lead to 10 million deaths annually, surpassing cancer as a leading cause of death. This alarming statistic highlights the urgent need for global action to combat this growing threat.To address the issue of antibiotic resistant (抗生素耐药) bacteria, a multifaceted approach is required. First and foremost, there needs to be an increase in public awareness regarding the responsible use of antibiotics. Patients should be educated on the importance of completing their prescriptions and avoiding the use of antibiotics for viral infections, such as the common cold.Healthcare professionals also play a crucial role in combating antibiotic resistant (抗生素耐药) bacteria. They must adhere to strict guidelines when prescribing antibiotics and consider alternative treatment options when appropriate. Additionally, hospitals and clinics should implement infection control measures to prevent the spread of resistant bacteria within healthcare settings.Moreover, governments and organizations must invest in research and development for new antibiotics and alternative therapies. This includes supporting initiatives that encourage pharmaceutical companies to prioritize the creation of new drugs and incentivizing innovations in treatment methods, such as bacteriophage therapy or vaccines.In conclusion, the challenge of antibiotic resistant (抗生素耐药) bacteria is one that requires immediate and coordinated action from individuals, healthcare providers, and policymakers alike. By promoting responsible antibiotic use, improving infection control practices, and investing in research, we can work together to preserve the effectiveness of antibiotics and safeguard public health for future generations. Failure to act could lead us back to a time when minor infections could once again become life-threatening, underscoring the importance of addressing this critical issue head-on.

抗生素一直是现代医学的基石，彻底改变了我们治疗感染和拯救生命的方式。然而，耐药细菌的出现对全球健康构成了重大威胁。这种现象发生在细菌进化并发展出能够在曾经有效杀死它们的抗生素暴露下存活的能力。因此，曾经容易治疗的感染变得越来越难以管理，导致住院时间延长、医疗费用增加以及死亡率上升。耐药细菌的兴起可以归因于几个因素，主要是人类和动物中抗生素的过度使用和误用。在许多情况下，患者没有完成处方的抗生素疗程，使一些细菌得以存活和适应。此外，抗生素常常用于牲畜养殖，以促进生长和预防疾病，这通过食物链将耐药性传播到人类群体中。另一个促成因素是新抗生素的开发缺乏。制药行业已将重点转向更有利可图的药物，导致针对耐药性感染的新治疗方法可用性显著不足。这种抗生素开发的停滞意味着医疗提供者在治疗不再响应标准疗法的感染时可选择的方案越来越少。耐药性感染的后果是可怕的。根据世界卫生组织（WHO）的估计，如果不采取行动，到2050年，耐药性感染每年可能导致1000万例死亡，超过癌症成为主要死亡原因。这一令人震惊的统计数据突显了全球行动应对这一日益严重威胁的紧迫性。为了解决耐药细菌的问题，需要采取多方面的方法。首先，必须提高公众对负责任使用抗生素的认识。应教育患者完成处方的重要性，并避免在病毒感染（如普通感冒）时使用抗生素。医疗专业人员在抗击耐药细菌方面也发挥着至关重要的作用。他们必须遵循严格的抗生素处方指南，并在适当时考虑替代治疗选择。此外，医院和诊所应实施感染控制措施，以防止耐药细菌在医疗环境中的传播。此外，各国政府和组织必须投资于新抗生素和替代疗法的研究与开发。这包括支持鼓励制药公司优先开发新药的倡议，并激励治疗方法的创新，例如噬菌体疗法或疫苗。总之，耐药细菌的挑战需要个人、医疗提供者和政策制定者立即协调行动。通过促进负责任的抗生素使用、改善感染控制实践和投资研究，我们可以共同努力维护抗生素的有效性，保护未来几代人的公共健康。如果不采取行动，轻微感染可能再次成为危及生命的威胁，这凸显了正面应对这一关键问题的重要性。